Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | W501* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | ALK W501* results in a premature truncation of the Alk protein at amino acid 501 of 1620 (UniProt.org). Due to the loss of the protein kinase domain (UniProt.org), W501* is predicted to lead to a loss of Alk protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
ALK mutant ALK inact mut ALK W501* |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29320795C>T |
| cDNA | c.1502G>A |
| Protein | p.W501* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304.5 | chr2:g.29320795C>T | c.1502G>A | p.W501* | RefSeq | GRCh38/hg38 |
| NM_004304.4 | chr2:g.29320795C>T | c.1502G>A | p.W501* | RefSeq | GRCh38/hg38 |
| NM_004304 | chr2:g.29320795C>T | c.1502G>A | p.W501* | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|